Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Management of fingolimod in clinical practice.

Thomas K, Ziemssen T.

Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S60-4. doi: 10.1016/j.clineuro.2013.09.023. Review.

PMID:
24321158
[PubMed - indexed for MEDLINE]
2.

Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.

Scott LJ.

CNS Drugs. 2011 Aug;25(8):673-98. doi: 10.2165/11207350-000000000-00000. Review.

PMID:
21790210
[PubMed - indexed for MEDLINE]
3.

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, Vollmer T, Agius MA, Kappos L, Stites T, Li B, Cappiello L, von Rosenstiel P, Lublin FD.

Lancet Neurol. 2014 Jun;13(6):545-56. doi: 10.1016/S1474-4422(14)70049-3. Epub 2014 Mar 28. Erratum in: Lancet Neurol. 2013 Jun;13(6):536.

PMID:
24685276
[PubMed - indexed for MEDLINE]
4.

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group.

N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20.

PMID:
20089952
[PubMed - indexed for MEDLINE]
Free Article
5.

Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis.

Singer B, Ross AP, Tobias K.

Int J Clin Pract. 2011 Aug;65(8):887-95. doi: 10.1111/j.1742-1241.2011.02721.x. Epub 2011 Jun 16. Review.

PMID:
21679286
[PubMed - indexed for MEDLINE]
6.

Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis.

Tanasescu R, Constantinescu CS.

Expert Opin Drug Metab Toxicol. 2014 Apr;10(4):621-30. doi: 10.1517/17425255.2014.894019. Epub 2014 Mar 1. Review.

PMID:
24579791
[PubMed - indexed for MEDLINE]
7.

[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis].

Kotov SV, Fedorova SI, Iakushina TI, Lizhdvoĭ VIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(2 Pt 2):74-8. Russian.

PMID:
23528598
[PubMed - indexed for MEDLINE]
8.

Fingolimod for the treatment of relapsing multiple sclerosis.

Singer BA.

Expert Rev Neurother. 2013 Jun;13(6):589-602. doi: 10.1586/ern.13.52. Review.

PMID:
23738997
[PubMed - indexed for MEDLINE]
9.

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.

Devonshire V, Havrdova E, Radue EW, O'Connor P, Zhang-Auberson L, Agoropoulou C, Häring DA, Francis G, Kappos L; FREEDOMS study group.

Lancet Neurol. 2012 May;11(5):420-8. doi: 10.1016/S1474-4422(12)70056-X. Epub 2012 Apr 10. Erratum in: Lancet Neurol. 2012 Aug;11(8):658.

PMID:
22494956
[PubMed - indexed for MEDLINE]
10.

Fingolimod for multiple sclerosis: a review for the specialist nurse.

Harrison K.

Br J Nurs. 2014 Jun 12-25;23(11):582-9. Review.

PMID:
24933548
[PubMed - indexed for MEDLINE]
11.

A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.

Saida T, Kikuchi S, Itoyama Y, Hao Q, Kurosawa T, Nagato K, Tang D, Zhang-Auberson L, Kira J.

Mult Scler. 2012 Sep;18(9):1269-77. doi: 10.1177/1352458511435984. Epub 2012 Feb 21.

PMID:
22354739
[PubMed - indexed for MEDLINE]
12.

Fingolimod for the treatment of relapsing multiple sclerosis.

Jeffery DR, Markowitz CE, Reder AT, Weinstock-Guttman B, Tobias K.

Expert Rev Neurother. 2011 Feb;11(2):165-83. doi: 10.1586/ern.10.193. Epub 2010 Dec 16. Review.

PMID:
21158700
[PubMed - indexed for MEDLINE]
13.

Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.

Sørensen PS.

J Neurol Sci. 2011 Dec;311 Suppl 1:S29-34.

PMID:
22206763
[PubMed - indexed for MEDLINE]
14.

Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.

Maciejek Z, Wójcik-Drączkowska H, Wawrzyniak S, Niezgodzińska-Maciejek A.

Neurol Neurochir Pol. 2013 Mar-Apr;47(2):145-51.

PMID:
23650003
[PubMed - indexed for MEDLINE]
15.

Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait.

Alroughani R, Ahmed SF, Behbehani R, Al-Hashel J.

Clin Neurol Neurosurg. 2014 Apr;119:17-20. doi: 10.1016/j.clineuro.2014.01.007. Epub 2014 Jan 21.

PMID:
24635919
[PubMed - indexed for MEDLINE]
16.

Fingolimod for relapsing multiple sclerosis: an update.

Horga A, Castilló J, Montalban X.

Expert Opin Pharmacother. 2010 May;11(7):1183-96. doi: 10.1517/14656561003769866. Review.

PMID:
20367536
[PubMed - indexed for MEDLINE]
17.

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group.

N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20.

PMID:
20089954
[PubMed - indexed for MEDLINE]
Free Article
18.

Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon beta-1a in patients with multiple sclerosis.

Agashivala N, Kim E.

Clin Ther. 2012 Jul;34(7):1583-90. doi: 10.1016/j.clinthera.2012.06.012. Epub 2012 Jun 28.

PMID:
22749258
[PubMed - indexed for MEDLINE]
19.

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

Comi G, O'Connor P, Montalban X, Antel J, Radue EW, Karlsson G, Pohlmann H, Aradhye S, Kappos L; FTY720D2201 Study Group.

Mult Scler. 2010 Feb;16(2):197-207. doi: 10.1177/1352458509357065. Epub 2009 Dec 22.

PMID:
20028707
[PubMed - indexed for MEDLINE]
20.

Fingolimod therapy for multiple sclerosis.

Willis MA, Cohen JA.

Semin Neurol. 2013 Feb;33(1):37-44. doi: 10.1055/s-0033-1343794. Epub 2013 May 25. Review.

PMID:
23709211
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk